APEI three-lens brief
Evidence-based stock research on APEI. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price up 5.17% in the last session — a material single-day move. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Price up 5.17% in the last session — a material single-day move.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Analyst mean target $60.50 — 43% above current (6 analysts).
- Reported earnings on 2026-11-09.
APEI closed at $42.28 (+5.17%) as of 2026-11-12. Market cap: $769.63M. P/E (trailing) 16.9. Price is below the 50-day MA and below the 200-day MA. Positives: price up 5.17% in the last session — a material single-day move.; analyst mean target $60.50 — 43% above current (6 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $169.14M, net income $5.89M, free cash flow $39.94M.
Why three lenses on APEI, not one.
A single reasoning model has blind spots it doesn’t know about. We examine APEI across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/APEI" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath APEI brief"></iframe>